CA Stock MarketDetailed Quotes
MBX Microbix Biosystems Inc
- 0.305
- -0.005-1.61%
15min DelayMarket Closed Nov 29 16:00 ET
41.69MMarket Cap8.24P/E (TTM)
0.320High0.305Low118.10KVolume0.320Open0.310Pre Close36.51KTurnover0.45052wk High0.10%Turnover Ratio136.70MShares0.28552wk Low0.037EPS TTM34.97MFloat Cap1.900Historical High0.00P/E (Static)114.67MShs Float0.000Historical Low--EPS LYR4.84%Amplitude--Dividend TTM1.49P/B1Lot Size--Div YieldTTM
Microbix Biosystems Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.51%5.06M | 33.53%5.63M | 236.04%8.41M | -13.43%16.51M | -1.50%4.26M | 10.36%5.53M | -13.57%4.22M | -48.47%2.5M | 2.60%19.08M | -23.10%4.33M |
| Operating revenue | -8.51%5.06M | 33.53%5.63M | 236.04%8.41M | -13.43%16.51M | -1.50%4.26M | 10.36%5.53M | -13.57%4.22M | -48.47%2.5M | 2.60%19.08M | -23.10%4.33M |
| Cost of revenue | -27.48%2.31M | 57.41%2.66M | 66.06%2.19M | 13.61%9.03M | 22.98%2.84M | 41.98%3.19M | -4.15%1.69M | -19.44%1.32M | 5.33%7.95M | -3.17%2.31M |
| Gross profit | 17.29%2.75M | 17.56%2.97M | 424.66%6.22M | -32.75%7.48M | -29.46%1.43M | -15.30%2.34M | -18.90%2.53M | -63.19%1.19M | 0.73%11.12M | -37.75%2.02M |
| Operating expense | -14.18%2.58M | 4.47%2.51M | 52.94%3.65M | 20.00%10.22M | 6.07%2.42M | 53.77%3.01M | 10.31%2.4M | 13.70%2.39M | 37.17%8.51M | 36.77%2.28M |
| Selling and administrative expenses | -18.50%2.02M | 7.33%2.02M | 61.38%3.17M | 22.19%8.01M | 1.03%1.69M | 57.88%2.48M | 12.02%1.88M | 20.01%1.96M | 29.17%6.56M | 37.30%1.67M |
| -Selling and marketing expense | -2.54%364.85K | -0.84%373.22K | 0.39%363.53K | -4.86%1.48M | -8.46%365.43K | -14.05%374.36K | -1.28%376.38K | 7.20%362.1K | 81.08%1.55M | 34.49%399.22K |
| -General and administrative expense | -21.34%1.66M | 9.37%1.64M | 75.17%2.8M | 30.60%6.53M | 4.01%1.32M | 85.50%2.1M | 15.94%1.5M | 23.34%1.6M | 18.61%5M | 38.21%1.27M |
| Research and development costs | 5.97%562.82K | -5.71%495.88K | 13.95%484.22K | 13.75%2.05M | 27.04%564.74K | 37.10%531.12K | 4.58%525.93K | -8.51%424.96K | 74.14%1.8M | 27.89%444.52K |
| Depreciation amortization depletion | ---- | ---- | ---- | 0.56%161.24K | ---- | ---- | ---- | ---- | 61.31%160.34K | ---- |
| -Depreciation and amortization | ---- | ---- | ---- | 0.56%161.24K | ---- | ---- | ---- | ---- | 61.31%160.34K | ---- |
| Operating profit | 124.80%165.31K | 273.41%459.06K | 313.77%2.57M | -204.84%-2.74M | -285.61%-990.56K | -182.40%-666.62K | -86.87%122.94K | -207.19%-1.2M | -46.03%2.61M | -116.25%-256.89K |
| Net non-operating interest income (expenses) | 16.87%-85.2K | 10.94%-81.33K | -17.93%-114.49K | 48.72%-381.64K | 30.17%-90.75K | 39.87%-102.49K | 55.04%-91.32K | 59.68%-97.08K | 53.57%-744.29K | 83.79%-129.96K |
| Non-operating interest income | 25.94%145.58K | 37.73%151.58K | 17.11%114.62K | 456.39%457.74K | 129.49%134.22K | 386.01%115.59K | --110.06K | --97.88K | 124,551.52%82.27K | 88,516.67%58.49K |
| Non-operating interest expense | 5.82%230.77K | 15.66%232.91K | 17.52%229.11K | 1.55%839.38K | 19.38%224.97K | 12.27%218.08K | -0.86%201.37K | -19.02%194.96K | -48.45%826.56K | -76.49%188.45K |
| Other net income (expenses) | 166.63K | 3.08M | ||||||||
| Special income (charges) | --166.63K | ---- | ---- | --3.08M | --3.08M | --0 | ---- | ---- | --0 | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---3.08M | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---166.63K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 132.08%246.75K | 1,094.74%377.73K | 288.98%2.46M | -102.12%-39.48K | 616.30%2M | -220.46%-769.11K | -95.69%31.62K | -247.51%-1.3M | -42.29%1.87M | -149.66%-386.85K |
| Income tax | 0 | 77.23K | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 132.08%246.75K | 1,094.74%377.73K | 288.98%2.46M | -102.21%-39.48K | 530.37%2M | -220.46%-769.11K | -95.69%31.62K | -247.51%-1.3M | -44.68%1.79M | -159.58%-464.08K |
| Net income continuous operations | 132.08%246.75K | 1,094.74%377.73K | 288.98%2.46M | -102.21%-39.48K | 530.37%2M | -220.46%-769.11K | -95.69%31.62K | -247.51%-1.3M | -44.68%1.79M | -159.58%-464.08K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 132.08%246.75K | 1,094.74%377.73K | 288.98%2.46M | -102.21%-39.48K | 530.37%2M | -220.46%-769.11K | -95.69%31.62K | -247.51%-1.3M | -44.68%1.79M | -159.58%-464.08K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 132.08%246.75K | 1,094.74%377.73K | 288.98%2.46M | -102.21%-39.48K | 530.37%2M | -220.46%-769.11K | -95.69%31.62K | -247.51%-1.3M | -44.68%1.79M | -159.58%-464.08K |
| Diluted earnings per share | 133.33%0.002 | 1,215.79%0.003 | 300.00%0.018 | -102.20%-0.0003 | 590.47%0.0147 | -220.00%-0.006 | -95.44%0.0002 | -228.57%-0.009 | -53.57%0.013 | -150.00%-0.003 |
| Basic earnings per share | 133.33%0.002 | 1,288.89%0.003 | 300.00%0.018 | -102.20%-0.0003 | 590.47%0.0147 | -250.00%-0.006 | -95.68%0.0002 | -250.00%-0.009 | -50.00%0.013 | -175.00%-0.003 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data